预防或逆转慢性炎症性风湿性疾病中的微生物组失生症的当前方法
Jan René Nkeck1,2, Ange Larissa Tchuisseu-Kwangoua1,3, Adeline Pelda1,2,4
1Yaoundé Rheumatology Research Team, Yaoundé, Cameroon.
微生物组失调影响慢性炎症性类风湿性疾病 (CIRD). 本综述涵盖了管理肠道健康的策略,以改善CIRD治疗和患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 类风湿病学 类风湿病学
背景情况:
- 肠道微生物组在免疫系统调节中起着至关重要的作用.
- 微生物组不平衡的失生症越来越多地与慢性炎症性类风湿性疾病 (CIRD) 的发展和进展有关.
- 了解微生物组-免疫轴对于破译CIRD病原性至关重要.
研究的目的:
- 在CIRD的背景下,审查目前用于预防或逆转微生物群失调的策略.
- 为管理CIRD患者的医疗保健专业人员提供实用见解.
- 突出微生物组改变对疾病决定性,临床表现和治疗反应的影响.
主要方法:
- 对微生物组失生症和CIRD现有研究的文献综述.
- 综合当前关于微生物组调节干预措施的知识.
- 分析dysbiosis对CIRD病原和治疗结果的影响.
主要成果:
- 微生物组失生症是CIRD发展和临床表现的一个重要因素.
- 可以采用各种方法来调节微生物群,可能会影响CIRD.
- 改变微生物组可能会影响患者对治疗的反应.
结论:
- 准微生物组失生症是CIRD的一个有前途的治疗途径.
- 基于证据的微生物组管理策略可以帮助临床医生治疗CIRD患者.
- 对微生物干预的进一步研究是有必要的,以优化CIRD管理.
更多相关视频
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
